Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Combivent Respimat (ipratropium/albuterol) and Symbicort (budesonide/formoterol) are both inhalers used to treat chronic obstructive pulmonary disease (COPD), but they have some key differences. Combivent Respimat combines a short-acting muscarinic antagonist (SAMA) and a short-acting beta-agonist (SABA), while Symbicort combines a corticosteroid and a long-acting beta-agonist (LABA). Combivent Respimat is typically taken 4 times a day but can be used up to 6 times a day, whereas Symbicort is used 2 times a day. Symbicort is also approved for treating asthma, while Combivent Respimat is not. Both medications must be taken every day and should not be used for sudden breathing problems. It may take up to 2 weeks for the maximum benefit of Symbicort to be felt. Additionally, Symbicort is available in generic forms, making it potentially more affordable than Combivent Respimat, which is only available as a brand medication.
Combivent respimat (ipratropium / albuterol)
Symbicort (budesonide / formoterol)
Combivent respimat (ipratropium / albuterol)
Symbicort (budesonide / formoterol)
Summary of Combivent vs. Symbicort
Summary for SAMA / SABA
Prescription only
Combivent Respimat is an inhaler that's used to treat chronic obstructive pulmonary disease (COPD) in adults. It's a combination medication that contains two different bronchodilators: ipratropium, a short-acting muscarinic antagonist (SAMA), and albuterol, a short-acting beta agonist (SABA). The medication is inhaled through the mouth 4 times a day, but up to 6 times per day if instructed. Combivent Respimat (ipratropium / albuterol) isn't a rescue inhaler; it's used regularly rather than as needed for sudden breathing problems. Side effects aren't common but can include upper respiratory tract infections and cough.
Summary for IC / LABA
Prescription only
Symbicort (budesonide / formoterol) is a combination inhaler containing a steroid (budesonide) and a long-acting beta-agonist (formoterol). Both medications work together to treat asthma and chronic obstructive pulmonary disease (COPD). The typical dose for Symbicort (budesonide / formoterol) is 2 inhalations by mouth twice a day, about 12 hours apart. Common side effects include symptoms of common cold, such as stuffy nose and cough. It's available in two different strengths, both with generic versions.